Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This pseudogene, catalogued as ENSG00000280828 and AC090114.3, is a genomic region in Homo sapiens that closely resembles parts of the gene Tousled-like kinase 2 (TLK2), a nuclear serine/threonine kinase[4][1][7]. By definition, a pseudogene is a nonfunctional segment of DNA that derives from a functional gene but harbors disabling mutations—such as premature stop codons or frameshifts—that prevent proper transcription or translation into a functional product[5]. Pseudogenes may arise by gene duplication, mutation, or retrotransposition, and are usually not transcribed or translated to produce functional proteins[2][5]. Although some pseudogenes can be transcribed and may occasionally exert regulatory effects (such as acting as RNA decoys), most do not have functional biological roles and do not serve as therapeutic targets[2][8]. Therefore, ENSG00000280828 is not considered a functional receptor, enzyme, or transporter, nor is it currently relevant as a biomarker or drug target in human disease biology. Essential distinctions: - This molecule is not the same as Tousled-like kinase 2 (TLK2), which is a protein-coding gene implicated in neurodevelopmental disorders and chromatin assembly[3][6]. - Pseudogenes can occasionally have regulatory functions, but no such role is established for this locus[2][8]. Summary for future structuring: ENSG00000280828, "Pseudogene similar to part of Tousled-like kinase 2," is a noncoding pseudogene – it is not a canonical target, lacks protein product, and does not participate in recognized therapeutic, biological, or diagnostic pathways[1][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of Tousled-like kinase 2.